WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR TherapeuticsTM, today announced that it will report financial results for the fourth quarter and year ended December 31, 2011 on Tuesday, February 21, 2012, after the U.S. financial markets close.
